Unichem Labs gets USFDA EIR for Roha API facility

Published On 2020-05-16 04:30 GMT   |   Update On 2020-05-16 04:30 GMT

Mumbai: Unichem Laboratories Limited has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredients (APIs) facility at Roha.The United States Food and Drug Administration (USFDA) conducted the inspection of the Company's Roha facility from 17th to 21st February 2020.Unichem Labs is one of India's...

Login or Register to read the full article

Mumbai: Unichem Laboratories Limited has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredients (APIs) facility at Roha.

The United States Food and Drug Administration (USFDA) conducted the inspection of the Company's Roha facility from 17th to 21st February 2020.

Unichem Labs is one of India's oldest pharmaceutical company headquartered in Mumbai, India.

The Company was founded by Late Mr Amrut V Mody in 1944.

Unichem manufactures and markets a large basket of pharmaceutical formulations across the globe including the regulated markets of the USA and Europe.

Read also: Alembic Pharma gets USFDA Final nod for Doxycycline Hyclate Tablets



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News